SCHEMBL7657058

SCHEMBL7657058

O=C(O)/C=C/c1ccc(N2CCCC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.54
PIM2 Q9P1W9 6/20 0.50
PTGS2 P35354 1/20 0.46
ESR1 P03372 2/20 0.45
MAPT P10636 2/20 0.44
UBE2T Q9NPD8 1/20 0.44
AOC3 Q16853 2/20 0.44
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PIM1 P11309 2/20 0.42
CSNK2A2 P19784 1/20 0.42
CSNK2A1 P68400 1/20 0.42
RAB9A P51151 1/20 0.42
CA12 O43570 1/20 0.42
AKR1B10 O60218 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657066 1.00 P4HTM (0.54) P4HTMPIM2PTGS2ESR1MAPT
SCHEMBL4619798 0.98 P4HTM (0.53) P4HTMPIM2PTGS2ESR1MAPT
SCHEMBL7482002 0.87 PIM2 (0.54) P4HTMPIM2ESR1MAPTALDH1A1
SCHEMBL3786486 0.87 PIM2 (0.54) P4HTMPIM2ESR1MAPTAOC3
SCHEMBL7482012 0.87 PIM2 (0.54) P4HTMPIM2ESR1MAPTALDH1A1
SCHEMBL29551688 0.87 PIM2 (0.54) P4HTMPIM2ESR1MAPTAOC3
SCHEMBL3786488 0.87 PIM2 (0.54) P4HTMPIM2ESR1MAPTAOC3
SCHEMBL16789345 0.86 PTGS2 (0.49) P4HTMPIM2PTGS2MAPTUBE2T
SCHEMBL4622159 0.82 CA12 (0.47) PTGS2MAPTAOC3ALDH1A1LMNA
SCHEMBL28395325 0.81 CA12 (0.52) PTGS2ESR1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462047-B1 CONTAINING 5- OR 6-MEMBERED OXYGEN, NITROGEN AND/OR SULFUR HETEROARYL GROUP; ANGINA, HYPERTENSION, RESPIRATORY DISTRESS, CONGESTIVE HEART FAILURE, RENAL FAILURE, ATHEROSCLEROSIS, INFLAMMATORY DISEASES, STROKES, BRONCHITIS, ASTHMA ICOS CORPORATION 2002-10-08 US disclosed